Sort
3,198 grants matching “mrna vaccine”
Development of a rapid response nucleic acid vaccine strategy for coronavirus epidemics
$955,395Kenneth C Bagley · Orlance, Inc. · R44 · FY2021 · AI
Implications of long germinal centers (GC) for T and B cell memory and mucosal immunity
$954,951Shane P Crotty · La Jolla Institute For Immunology · U19 · FY2025 · AI
Combining membrane Env vaccine regimens to elicit multiple bnAb lineages and consistent cross-neutralization of HIV
$953,504Michael B Zwick · Scripps Research Institute, The · R01 · FY2024 · AI
Molecular approaches to understand vector-host and vector-pathogen interactions
$953,262Jesus Valenzuela · Niaid Extramural Activities · Z01 · FY2007 · AI
Specific Pathogen Free Baboon Research Resource (SPFBRR)
$946,402Christian R Abee · University Of Tx Md Anderson Can Ctr · P40 · FY2017 · OD
Host Immune Responses to Antigens of Malaria Parasites
$946,156Carole Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Self-Assembling Spike-EBR Nanoparticles as a Vaccine Platform Technology Against SARS-CoV-2 and Future Pandemic Coronaviruses
$945,000Magnus Adrian Gero Hoffmann · J. David Gladstone Institutes · DP5 · FY2025 · OD
Fox COBRE Phase II Admin Core
$944,312Joseph M Fox · University Of Delaware · P20 · FY2023 · GM
Strategies for targeting T follicular helper cells to improve HIV Env vaccine immunogenicity and efficacy
$942,815Ellen Elizabeth Sparger · University Of California At Davis · P01 · FY2025 · AI
Project 1 - Development of mRNA Immunogens for Protective Antibody Induction
$942,168Barton F Haynes · Duke University · U19 · FY2020 · AI
Structural characterization of MPER-TM immunogens
$940,588Ellis L Reinherz · Dana-Farber Cancer Inst · P01 · FY2024 · AI
Engineering the Immune Response of a Self-replicating and Adjuvanting RNA HIV-1Vaccine
$940,253Amit Praful Khandhar · Hdt Bio Corporation · R61 · FY2023 · AI
Mechanisms and Duration of Immunity to SARS-CoV-2 - Supplement Application for Sept 2024-Aug 2025
$939,222Scott Dexter Boyd · Stanford University · U54 · FY2024 · CA
CCR Genomics Core
$937,890Elizabeth Conner · Division Of Basic Sciences - Nci · ZIC · FY2018 · CA
Targeting the Epigenome for Lung Cancer Therapy
$936,250David Schrump · Division Of Clinical Sciences - Nci · Z01 · FY2008 · CA
Project 3: Nucleoside-modified mRNA-LNP vaccine platform
$936,112Barton F Haynes · Duke University · P01 · FY2023 · AI
Non-human Primate (NHP Core)
$929,192James L Riley · University Of Pennsylvania · P01 · FY2025 · AI
Development of Nipah virus mRNA vaccine
$929,036Rosemarie Mason · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Vaccines and Therapeutics for Anthrax
$928,890Stephen Leppla · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Engineering the Immune Response of a Self-replicating and Adjuvanting RNA HIV-1Vaccine
$927,069Amit Praful Khandhar · Hdt Bio Corporation · R61 · FY2021 · AI
High-throughput Discovery of Antibodies against Understudied Membrane Proteins using mRNA
$923,143Ross S Chambers · Integral Molecular · R44 · FY2025 · GM
Novel Targets for Vaccine Therapy
$923,127Claudia Palena · Division Of Basic Sciences - Nci · ZIC · FY2011 · CA
BASE TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMAKERSTASK ORDER TITLE: VACCINES AGAINST FUSOBACTERIUM FOR FAP-AND LYNCH SYNDROME-ASSOCIA
$921,373Margie Clapper · Research Inst Of Fox Chase Can Ctr · N01 · FY2024 · CA
Small Molecule Inhibitors of Ebola Virus Polymerase Function
$918,430Christopher F Basler · Georgia State University · R01 · FY2017 · AI
Assessment of Clinical Grade Near-Native Cleavage-Independent Trimer Protein Compared to Membrane-Bound mRNA Expression Coupled with Glycan Deletion, Restoration and Heterologous Boosting
$918,112Pyone Aye · Tulane University Of Louisiana · N01 · FY2021 · AI